Centuries ago medical professionals became aware of the connection between yeast infections and much larger underlying diseases such as malignant tumors, diabetes mellitus and chronic infections. Recent studies show that another disease that can be connected with the presence of these infections is Cancer!
A recent study, “Candida Albicans and Cancer: Can This Yeast Induce Cancer Development or Progression?”, published in Critical Reviews in Microbiology, addresses the connection between yeast infections and Cancer. The results not only found that the yeast was a by-product of cancer, but that it was actually acting as a contributor to the disease!
The authors of the study wrote:
“There is currently increasing concern about the relation between microbial infections and cancer. More and more studies support the view that there is an association, above all, when the causal agents are bacteria or viruses. This review adds to this, summarizing evidence that the opportunistic fungus Candida Albicans increases the risk of carcinogenesis and metastasis. Until recent years, Candida spp. Had fundamentally been linked to cancerous processes as it is an opportunist pathogen that takes advantage of the immunosuppressed state of patients particularly due to chemotherapy.
In contrast, the most recent findings demonstrate that C. Albicans is capable of promoting cancer by several mechanisms, as described in the review: production of carcinogenic byproducts, triggering of inflammation, induction of Th17 response and molecular mimicry. We underline the need not only to control this type of infection during cancer treatment, especially given the major role of this yeast species in nosocomial infections, but also to find new therapeutic approaches to avoid the pro-tumor effect of this fungal species.”
The second study, “Curcumin and Its Promise as an Anti-Cancer Drug: An Analysis of its Anti-Cancer and Anti-Fungal Effects in Cancer and Associated Complications from Invasive Fungal Infections” focused on the healing powers of curcumin, the primary polyphenol found in turmeric. Curcumin has a heightened ability to withstand attacks from free radicals within the body, allowing it to protect the body against fungal infections.
The authors of the study revealed:
“Curcumin, a natural component that is isolated from the rhizome of Curcuma longa plants, has attracted great interest among many scientists studying solid cancers over the last half century. Interestingly, curcumin provides an ideal alternative to current therapies because of its relatively safe profile, even at high doses. To date, curcumin’s potent antifungal activity against different strains of Candida, Cryptococcus, Aspergillus, Trichosporon and Paracoccidioides have been reported, indicating that curcumin anticancer drugs may also possess an antifungal role, helping cancer patients to resist invasive fungal infection related complications. The aim of this review is to discuss curcumin’s dual pharmacological activities regarding its applications as a natural anticancer and antifungal agent. These dual pharmacological activities are expected to lead to clinical trials and to improve infection survival among cancer patients.
Curcumin is an up-and-coming drug of natural origin with multi-target properties and it has exhibited efficient anticancer and antifungal activities alone or in combination with conventional chemotherapy drugs and antifungal agents. The dual pharmacological activities of curcumin may make it a good candidate for the prevention and treatment of cancer and its cancer-related invasive fungal infection related complications.”
Traditional cancer therapies in use today come with a long list of side effects, including:
- Damage to the patient’s immune system
- The risk of developing treatment-resistant fungal infections
- Kidney Damage
- Liver Damage
These studies illustrated the power of Turmeric in the fight against cancer. It’s ability to fight fungal infections without the side effects of traditional cancer treatments is worth of further investigation.
